<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T08:56:11Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:20.500.12327/4732" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:20.500.12327/4732</identifier><datestamp>2025-10-22T11:10:06Z</datestamp><setSpec>com_2072_4428</setSpec><setSpec>com_2072_4427</setSpec><setSpec>col_2072_487898</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Comparison of Three Commercial ELISA Kits for Detection of Antibodies Against SARS-CoV-2 in Serum Samples from Different Animal Species</dc:title>
   <dc:creator>Fernández-Bastit, Leira</dc:creator>
   <dc:creator>Marfil, Sílvia</dc:creator>
   <dc:creator>Pradenas, Edwards</dc:creator>
   <dc:creator>Blanco, Julià</dc:creator>
   <dc:creator>Vergara-Alert, Júlia</dc:creator>
   <dc:creator>Segalés, Joaquim</dc:creator>
   <dc:contributor>Producció Animal</dc:contributor>
   <dc:contributor>Sanitat Animal</dc:contributor>
   <dc:subject>619</dc:subject>
   <dc:description>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the coronavirus disease 19 (COVID-19) pandemic, significantly impacting global health, economies, and social stability. In February 2020, the first cases of SARS-CoV-2 infections in animals were documented, highlighting the potential risks posed by regular human–animal interactions in facilitating viral transmission. In consequence, it is essential to validate surveillance methods for SARS-CoV-2 in animals. In the present study, 101 sera from different animal species (36 cats, 41 dogs, 4 ferrets, 10 wild boar, 6 domestic goats, and 4 lions) were tested using three different ELISA kits to evaluate humoral responses against SARS-CoV-2. ELISA results were compared and correlated with a pseudovirus neutralization test (pVNT), considered as the reference assay. ELISA-1, targeting the receptor binding domain (RBD) neutralizing antibodies (nAbs) of SARS-CoV-2, exhibited the highest diagnostic performance, and proved to be a reliable tool for initial screenings in high-throughput animal studies. In contrast, ELISA-2 (also targeting RBD nAbs) and ELISA-3 (targeting nucleoprotein antibodies) demonstrated lower sensitivity for detecting seropositive animals.</dc:description>
   <dc:description>This research was partially funded by the BBVA Foundation as part of the project ‘Investigation on the potential role of pets as animal reservoirs for SARS-CoV-2’. The authors also acknowledge the crowdfunding initiative #Yomecorono, available online at https://www.yomecorono.com (accessed on 12 December 2024). IRTA (2021 SGR 00825 and 2021 SGR 01385) and IrsiCaixa (2021 SGR 00452) are supported by CERCA Programme/Generalitat de Catalunya.</dc:description>
   <dc:description>info:eu-repo/semantics/publishedVersion</dc:description>
   <dc:date>2025-05-16</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:identifier>Fernández-Bastit, Leira, Sílvia Marfil, Edwards Pradenas, Julià Blanco, Júlia Vergara-Alert, and Joaquim Segalés. 2025. “Comparison of Three Commercial ELISA Kits for Detection of Antibodies Against SARS-CoV-2 in Serum Samples From Different Animal Species.” Viruses 17 (5): 716. https://doi.org/10.3390/v17050716.</dc:identifier>
   <dc:identifier>1999-4915</dc:identifier>
   <dc:identifier>http://hdl.handle.net/20.500.12327/4732</dc:identifier>
   <dc:identifier>https://doi.org/10.3390/v17050716</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Viruses</dc:relation>
   <dc:rights>Attribution 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>16</dc:format>
   <dc:publisher>MDPI</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>